دورية أكاديمية

Efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis of randomized controlled trials.

التفاصيل البيبلوغرافية
العنوان: Efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis of randomized controlled trials.
المؤلفون: Qiu, Yunfeng, Li, Changfeng, Sheng, Shihou
المصدر: Stem Cell Research & Therapy; 2/2/2024, Vol. 15 Issue 1, p1-16, 16p
مستخلص: Purpose: Small-scale clinical trials have provided evidence suggesting the effectiveness of stem-cell therapy (SCT) for patients diagnosed with Crohn's disease (CD). The objective of the research was to systematically assess the effectiveness and safety of SCT for individuals diagnosed with CD through a comprehensive review and meta-analysis. Methods: A search was conducted in Medline (PubMed), CENTER (Cochrane Library), and Embase (Ovid) to find randomized controlled trials (RCTs) that assessed the impact of SCT on the occurrence of clinical remission (CR) and severe adverse events (SAE) among patients diagnosed with CD. The Cochrane Q test and estimation of I2 were used to assess heterogeneity among studies. After incorporating heterogeneity, a random-effects model was employed for data pooling. Results: Overall, 12 RCTs involving 632 adult patients with medically refractory CD or CD-related fistula were included. In comparison with placebo or no treatment, SCT showed a greater likelihood of CR (odds ratio [OR] 2.08, 95% CI 1.39–3.12, p < 0.001) without any notable heterogeneity (I2 = 0%). Consistent results were observed in subgroup analyses based on study design, patient diagnosis, source and type of stem cells, and follow-up durations, with all p-values for subgroup analyses being greater than 0.05. The occurrence of SAE was similar among patients assigned to SCT and the placebo/no treatment cohorts (OR 0.70, 95% CI 0.37–1.33, p = 0.28; I2 = 0%). Conclusions: For patients with medically refractory CD or CD-related fistula, SCT may be an alternatively effective and safe treatment. [ABSTRACT FROM AUTHOR]
Copyright of Stem Cell Research & Therapy is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:17576512
DOI:10.1186/s13287-024-03637-z